Abstract
Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.
| Original language | English |
|---|---|
| Pages (from-to) | 831-836 |
| Number of pages | 6 |
| Journal | Antiviral Therapy |
| Volume | 18 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 2013 |
Fingerprint
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
- Medicine(all)
Cite this
Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings : Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network. / Pillay, Deenan; Deenan, Jan; Bertagnolio, Silvia; Boucher, Charles; Brun-Vezinet, Francoise; Clotet, Bonaventura; Giaquinto, Carlo; Perno, Carlo F.
In: Antiviral Therapy, Vol. 18, No. 6, 2013, p. 831-836.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Implications of HIV drug resistance on irst- and second-line therapies in resource-limited settings
T2 - Report from a workshop organized by the Collaborative HIV and Anti-HIV Drug Resistance Network
AU - Pillay, Deenan
AU - Deenan, Jan
AU - Bertagnolio, Silvia
AU - Boucher, Charles
AU - Brun-Vezinet, Francoise
AU - Clotet, Bonaventura
AU - Giaquinto, Carlo
AU - Perno, Carlo F.
PY - 2013
Y1 - 2013
N2 - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.
AB - Here, we summarize the discussions and conclusions from an expert workshop held in October 2012 to consider the implications of HIV drug resistance in the context of scale-up of access to antiretroviral therapy and prophylaxis in resource-limited settings. Topics considered during the workshop included the implications of drug resistance for the selection of irst-line regimens and sequencing of treatments, optimal surveillance strategies and prevention of mother-to-child transmission.
UR - http://www.scopus.com/inward/record.url?scp=84890364624&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84890364624&partnerID=8YFLogxK
U2 - 10.3851/IMP2650
DO - 10.3851/IMP2650
M3 - Article
VL - 18
SP - 831
EP - 836
JO - Antiviral Therapy
JF - Antiviral Therapy
SN - 1359-6535
IS - 6
ER -